Zhu Bingbing, Zhao Xinping, Li Yurong, Wang Na, Lambert Helen, Yan Fei, Jiang Qingwu, Fu Chaowei
Key Laboratory of Public Health Safety, NHC Key Laboratory of Health Technology Assessment, School of Public Health, Fudan University, Shanghai 200032, China.
Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK.
Antibiotics (Basel). 2022 Nov 3;11(11):1544. doi: 10.3390/antibiotics11111544.
There are growing concerns that the coronavirus disease of 2019 (COVID-19) pandemic may change antibiotic use patterns and accelerate antibiotic resistance, but evidence from the community level is lacking. This study aims to estimate the impact of the COVID-19 outbreak on the antibiotic use patterns among a community population in Eastern China. A self-administered medicine diary was used to collect information on antibiotic use from July 2019 to June 2021 among a rural community in Eastern China. We analyzed the changes in antibiotic use patterns over five months from August to December 2019 and the corresponding months in 2020. The risk of antibiotic use and its changes were measured with the incidence rate (IR) and relative risk (RR). In total, 1111 participants were eligible for the final analysis (440 in 2019 and 671 in 2020). After the COVID-19 outbreak, antibiotic use increased by 137% (5.43 per 100 person months in the 2019 vs. 12.89 per 100 person months in the 2020), and after the adjustment of covariates, the adjusted RR was 1.72 (95% CI: 1.10~2.34). It was higher among those who were women (RR = 2.62), aged 35−59 years old (RR = 2.72), non-farmers (RR = 2.75), had less than six years of education (RR = 2.61), had an annual household income over CNY 100,000 (USD 14,940) (RR = 2.60), and had no history of chronic diseases (RR = 2.61) (all p < 0.05). The proportion of cephalosporins consumed increased from 54.29% in 2019 to 64.92% in 2020 (p = 0.011). Among those aged 35 years and older, the proportion of antibiotics obtained from medical facilities increased, while the proportion obtained from retail pharmacies, homes, and other sources decreased (all p < 0.05). The COVID-19 outbreak changed antibiotic use patterns in this study population (Eastern China) significantly. More efforts to monitor and enhance antibiotic stewardship activities at the community level are needed in future.
人们越来越担心2019冠状病毒病(COVID-19)大流行可能会改变抗生素使用模式并加速抗生素耐药性,但社区层面的证据尚缺。本研究旨在评估COVID-19疫情对中国东部一个社区人群抗生素使用模式的影响。采用自行填写的用药日记收集2019年7月至2021年6月期间中国东部一个农村社区的抗生素使用信息。我们分析了2019年8月至12月以及2020年相应月份这五个月期间抗生素使用模式的变化。抗生素使用风险及其变化用发病率(IR)和相对风险(RR)来衡量。共有1111名参与者符合最终分析条件(2019年440名,2020年671名)。COVID-19疫情爆发后,抗生素使用量增加了137%(2019年为每100人月5.43次,2020年为每100人月12.89次),在调整协变量后,调整后的RR为1.72(95%CI:1.10~2.34)。女性(RR = 2.62)、年龄在35至59岁之间(RR = 2.72)、非农民(RR = 2.75)、受教育年限少于六年(RR = 2.61)、家庭年收入超过10万元人民币(14,940美元)(RR = 2.60)以及无慢性病病史者(RR = 2.61)的抗生素使用风险更高(均p < 0.05)。头孢菌素的消费比例从2019年的54.29%增至2020年的64.92%(p = 0.011)。在35岁及以上人群中,从医疗机构获取抗生素的比例增加,而从零售药店、家中及其他来源获取抗生素的比例下降(均p < 0.05)。COVID-19疫情显著改变了本研究人群(中国东部)的抗生素使用模式。未来需要在社区层面加大监测力度并加强抗生素管理活动。